The competitive landscape of the robotic surgery market is heating up as Medtronic’s Hugo robotic-assisted surgery (RAS) system secures three new regulatory approvals in Europe, Japan, and Canada.
The general surgery indication in Europe and Canada and the Ministry of Health, Labour and Welfare approval for use in gynecologic and urologic procedures in Japan bolsters Medtronic’s strategy to drive robotic surgery adoption worldwide, tapping into a lucrative market that has been dominated exclusively by Intuitive Surgical for almost two decades.
